XML 29 R16.htm IDEA: XBRL DOCUMENT v3.3.1.900
Segment information
3 Months Ended
Jan. 31, 2016
Segment Reporting [Abstract]  
Segment information
Note 10 - Segment information
   
The Company aggregates operating divisions into operating segments which have similar economic characteristics primarily in the following areas: (1) the nature of the product and services; (2) the nature of the production process; (3) the type or class of customer for their products and services; (4) the methods used to distribute their products or services; (5) if applicable, the nature of the regulatory environment. As of January 31, 2016, the Company had three segments based upon this evaluation - RF Connector and Cable Assembly, Custom Cabling Manufacturing and Assembly and Medical Cabling and Interconnector. As discussed in Note 17 below, the Company has decided to close the Medical Cabling and Interconnect segment.
 
During the fiscal quarter ended January 31, 2016, the RF Connector and Cable Assembly segment consisted of two divisions, the Custom Cabling Manufacturing and Assembly segment was composed of three divisions and the Medical Cabling and Interconnector segment consisted of one division. The five divisions that meet the quantitative thresholds for segment reporting are Connector and Cable Assembly, Cables Unlimited, Comnet, Bioconnect and Rel-Tech. The other division aggregated into the RF Connector and Cable Assembly segment and into the Custom Cabling Manufacturing and Assembly segment has similar products that are marketed to their respective customer base and production and product development processes that are similar in nature. The specific customers are different for each division; however, there is some overlapping of product sales to them. The methods used to distribute products are similar within each division aggregated.
 
Management identifies the Company’s segments based on strategic business units that are, in turn, based along market lines. These strategic business units offer products and services to different markets in accordance with their customer base and product usage. For segment reporting purposes, the Company aggregated the Connector and Cable Assembly and Aviel (until the time of sale) divisions into the RF Connector and Cable Assembly segment, and the Cables Unlimited, Comnet and Rel-Tech division constituted the Custom Cabling Manufacturing and segment. The Bioconnect division comprised the Medical Cabling and Interconnector segment.
 
As reviewed by the Company’s chief operating decision maker, the Company evaluates the performance of each segment based on income or loss before income taxes. The Company charges depreciation and amortization directly to each division within the segment. Accounts receivable, inventory, property and equipment, goodwill and intangible assets are the only assets identified by segment. Except as discussed above, the accounting policies for segment reporting are the same for the Company as a whole.
 
Substantially all of the Company’s operations are conducted in the United States; however, the Company derives a portion of its revenue from export sales. The Company attributes sales to geographic areas based on the location of the customers. The following table presents the sales of the Company by geographic area for the three months ended January 31, 2016 and 2015 (in thousands):
 
 
 
Three Months Ended January 31,
 
 
 
2016
 
2015
 
 
 
 
 
 
 
United States
 
$
6,692
 
$
6,596
 
Foreign Countries:
 
 
 
 
 
 
 
Canada
 
 
71
 
 
114
 
Israel
 
 
62
 
 
52
 
Mexico
 
 
97
 
 
94
 
All Other
 
 
62
 
 
38
 
 
 
 
292
 
 
298
 
 
 
 
 
 
 
 
 
Totals
 
$
6,984
 
$
6,894
 
 
Net sales, income (loss) from continuing operations before benefit for income taxes and other related segment information for the three months ended January 31, 2016 and 2015 are as follows (in thousands): 
  
 
 
RF Connector
 
Custom Cabling
 
Medical
 
 
 
 
 
 
 
and
 
Manufacturing and
 
Cabling and
 
 
 
 
 
2016
 
Cable Assembly
 
Assembly
 
Interconnector
 
Corporate
 
Total
 
Net sales
 
$
1,956
 
$
4,828
 
$
200
 
$
-
 
$
6,984
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loss from continuing operations before benefit for income taxes
 
 
(415)
 
 
(118)
 
 
(78)
 
 
-
 
 
(611)
 
Depreciation and amortization
 
 
46
 
 
220
 
 
6
 
 
-
 
 
272
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
$
2,701
 
$
3,617
 
$
576
 
$
-
 
$
6,894
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Income (loss) from continuing operations before benefit for income taxes
 
 
65
 
 
(164)
 
 
125
 
 
5
 
 
31
 
Depreciation and amortization
 
 
41
 
 
144
 
 
5
 
 
-
 
 
190